The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.

Eight children with severe autoimmune diseases who did not respond to conventional therapies were able to completely stop ...

AbbVie Inc. stays a Strong Buy after a Q4 2025 earnings beat led by HUMIRA, plus growth in immunology and neuroscience. Click ...

AbbVie has submitted applications to the FDA and EMA for new indications for upadacitinib (RINVOQ 15-mg) for the treatment of adult and adolescent patients living with non-segmental vitiligo (NSV), ...

CONGRESSWOMAN Girlie Veloso of Malasakit@Bayanihan Party-list filed House Bill (HB) 7302 in the House of Representatives on ...

The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...

This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 22, 2026, Health Canada has approved Gazyva® ...

The 50-year-old, who shot to fame as part of band Eternal in the early 90s, joined Christine Lampard, Nadia Sawalhaand Jane ...

Background: Kikuchi-Fujimoto disease (KFD) is a rare, self-limiting lymphadenitis predominantly affecting children and young adults, often mimicking lymphoma or tuberculous lymphadenitis. Although it ...

Driving AUCATZYL® top line growth Optimizing manufacturing operation to improve gross margin and innovating on next generation manufacturing platform Progressing the CATULUS, LUMINA and BOBCAT trials ...

Please provide your email address to receive an email when new articles are posted on . Telitacicept yielded a positive response to the modified SLE Responder Index-4 vs. placebo. The drug is not yet ...